Small Molecules

12 Oct 2007 Threshold Pharmaceuticals to Stop Enrollment in Clinical Trial
12 Oct 2007 Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
11 Oct 2007 VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
11 Oct 2007 ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
11 Oct 2007 Wyeth and Zealand Pharma Advance the First Orally Available Gap Junction Modifier into Phase I Clinical Trials
11 Oct 2007 ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
11 Oct 2007 GlaxoSmithKline and Synta Pharmaceuticals Announce Development and Commercialization Collaboration for STA-4783 in Oncology
11 Oct 2007 Alcon Amends NDA for Patanase(R) Nasal Spray
11 Oct 2007 Pharmion and MethylGene Initiate Phase One Combination Clinical Trial with MGCD0103 and Taxotere(R) in Patients with Solid Tumors
11 Oct 2007 Proteolix Initiates Multicenter Open-label Study of the Safety andActivity of Carfilzomib in Subjects with Relapsed Solid Tumors
10 Oct 2007 Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
10 Oct 2007 Sciele Completes Enrollment of Patients in Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
10 Oct 2007 SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
09 Oct 2007 MediciNova Reports Positive Phase IIa Clinical Study Results for MN-221, a Novel Treatment for Status Asthmaticus
09 Oct 2007 Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Hospital-Acquired Pneumonia
09 Oct 2007 Jerini Ophthalmic Treats First Patient in Phase I Trial for Age-related Macular Degeneration
09 Oct 2007 deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
09 Oct 2007 Sirtris Pharmaceuticals' Oral Drug Candidate SRT501 Shown To Be Neuroprotective: Implications for SIRT1 Activation in Neurodegenerative Eye Disorders
09 Oct 2007 NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
09 Oct 2007 Enrollment Complete in Pivotal Phase III Trial of Medidur(TM)FA for Diabetic Macular Edema
09 Oct 2007 4SC AG: Patient Treatment in Phase IIa Clinical Trial Completed
09 Oct 2007 New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
09 Oct 2007 Xanthus Initiates Pivotal Phase 3 Trial of Xanafide in Secondary Acute Myeloid Leukemia
09 Oct 2007 Metabasis Therapeutics Presents Preclinical Results for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia at the American Thyroid Association's National Meeting
09 Oct 2007 Accentia Announces Investigational New Drug Application for Revimmune Usage in a Pivotal Phase 3 Study of Refractory Multiple Sclerosis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up